Home > Boards > US Listed > Biotechs > MultiCell Technologies (MCET)

Latest Information Update: 28 Sep 2018: MCT-465

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
TPX Member Profile
Member Level 
Followed By 632
Posts 37,447
Boards Moderated 6
Alias Born 10/24/13
160x600 placeholder
TPX Member Level  Monday, 10/08/18 01:04:25 PM
Re: None
Post # of 43277 
Latest Information Update: 28 Sep 2018: MCT-465

MCT 465
Alternative Names: MCT-465
Latest Information Update: 28 Sep 2018

At a glance
Originator MultiCell Technologies Inc
Developer MultiCell Technologies Inc; University Health Network
Class Antivirals; RNA
Mechanism of Action Angiogenesis inhibitors; Apoptosis stimulants; Immunostimulants; T lymphocyte stimulants; Toll-like receptor agonists
Orphan Drug Status No
New Molecular Entity Yes
Highest Development Phases
No development reported Cancer; Liver cancer; Viral hepatitis
Discontinued Influenza virus infections
Most Recent Events
28 Sep 2018 No recent reports of development identified for preclinical development in Viral-hepatitis in USA (Parenteral)
04 Nov 2017 No recent reports of development identified for preclinical development in Cancer in USA (Parenteral)
04 Nov 2017 No recent reports of development identified for preclinical development in Liver-cancer in USA (Parenteral)

https://adisinsight.springer.com/drugs/800023642

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist